{
    "nctId": "NCT03974204",
    "briefTitle": "Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.",
    "officialTitle": "Benefit of Analyzing Exosomes in the Cerebrospinal Fluid During the Medical Care of Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer, Leptomeningeal Metastasis",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Proteomic profiles issued from cerebrospinal fluid at diagnosis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient with histologically proven breast cancer\n* Patient with suspected metastatic leptomeningitis\n* Age \u2265 18 years\n* Patient covered by the French social security regime\n* Signed written informed consent\n\nExclusion Criteria:\n\n* History of cancer other than the one being treated\n* Contraindication to carrying out the lumbar puncture or cerebrospinal MRI\n* Pregnant or breastfeeding patient",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}